deltatrials
Completed PHASE3 NCT01935557

Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation

Sponsor: Yong Seog Oh

Conditions Coagulation; Intravascular
Interventions Continuous heparin infusion Intermittent heparin infusion
Updated 6 times since 2017 Last updated: Apr 13, 2016 Started: Dec 31, 2012 Primary completion: Jul 31, 2015 Completion: Dec 31, 2015

Listed as NCT01935557, this PHASE3 trial focuses on Coagulation; Intravascular and remains completed. Sponsored by Yong Seog Oh, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Yong Seog Oh
Data source: Seoul St. Mary's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Seoul, South Korea